Concepts (178)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Radiology | 4 | 2023 | 126 | 1.630 |
Why?
|
| Positron-Emission Tomography | 9 | 2021 | 295 | 1.600 |
Why?
|
| Artificial Intelligence | 7 | 2026 | 329 | 1.180 |
Why?
|
| Fluorodeoxyglucose F18 | 8 | 2021 | 126 | 1.160 |
Why?
|
| Magnetic Resonance Imaging | 9 | 2026 | 3911 | 0.970 |
Why?
|
| Diagnostic Imaging | 3 | 2025 | 300 | 0.950 |
Why?
|
| Multimodal Imaging | 7 | 2017 | 113 | 0.950 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2025 | 35 | 0.880 |
Why?
|
| Radiology Information Systems | 2 | 2021 | 26 | 0.840 |
Why?
|
| Positron Emission Tomography Computed Tomography | 3 | 2021 | 79 | 0.710 |
Why?
|
| Tomography, X-Ray Computed | 8 | 2026 | 2116 | 0.700 |
Why?
|
| Gastroparesis | 4 | 2024 | 69 | 0.690 |
Why?
|
| Workflow | 2 | 2021 | 139 | 0.680 |
Why?
|
| Referral and Consultation | 1 | 2025 | 566 | 0.670 |
Why?
|
| Hip Dislocation | 4 | 2026 | 36 | 0.670 |
Why?
|
| Burnout, Professional | 1 | 2023 | 131 | 0.660 |
Why?
|
| Intestinal Volvulus | 3 | 2025 | 39 | 0.640 |
Why?
|
| Child | 39 | 2026 | 26240 | 0.640 |
Why?
|
| Radiography | 6 | 2024 | 760 | 0.610 |
Why?
|
| Ultrasonography | 7 | 2025 | 972 | 0.600 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2021 | 200 | 0.590 |
Why?
|
| Histiocytosis | 1 | 2017 | 18 | 0.530 |
Why?
|
| Lung Diseases | 1 | 2021 | 400 | 0.510 |
Why?
|
| Pandemics | 4 | 2022 | 1160 | 0.500 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2014 | 283 | 0.490 |
Why?
|
| Digestive System Abnormalities | 3 | 2025 | 38 | 0.490 |
Why?
|
| Breast | 2 | 2014 | 216 | 0.480 |
Why?
|
| Radiopharmaceuticals | 8 | 2021 | 165 | 0.460 |
Why?
|
| Whole Body Imaging | 1 | 2014 | 30 | 0.430 |
Why?
|
| Humans | 54 | 2026 | 131501 | 0.400 |
Why?
|
| Dyspepsia | 3 | 2024 | 108 | 0.390 |
Why?
|
| Ileal Diseases | 2 | 2024 | 27 | 0.390 |
Why?
|
| Radiologists | 3 | 2022 | 54 | 0.390 |
Why?
|
| Intestinal Obstruction | 2 | 2024 | 86 | 0.390 |
Why?
|
| Lymphoma | 1 | 2016 | 330 | 0.380 |
Why?
|
| Intussusception | 2 | 2024 | 54 | 0.380 |
Why?
|
| Scoliosis | 2 | 2024 | 145 | 0.370 |
Why?
|
| Breast Neoplasms | 2 | 2014 | 2646 | 0.350 |
Why?
|
| Thyroid Neoplasms | 2 | 2025 | 248 | 0.330 |
Why?
|
| Hospitals, Pediatric | 4 | 2025 | 794 | 0.330 |
Why?
|
| Foreign Bodies | 2 | 2021 | 102 | 0.320 |
Why?
|
| Adolescent | 19 | 2026 | 20918 | 0.300 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 2 | 2026 | 55 | 0.280 |
Why?
|
| Gastrointestinal Diseases | 2 | 2022 | 340 | 0.280 |
Why?
|
| Gastric Emptying | 3 | 2024 | 78 | 0.270 |
Why?
|
| Radiology Department, Hospital | 2 | 2020 | 26 | 0.260 |
Why?
|
| Enema | 2 | 2024 | 47 | 0.260 |
Why?
|
| Retrospective Studies | 18 | 2026 | 17648 | 0.250 |
Why?
|
| Neuroblastoma | 2 | 2023 | 557 | 0.250 |
Why?
|
| Lung Neoplasms | 3 | 2023 | 1541 | 0.250 |
Why?
|
| Femoracetabular Impingement | 1 | 2026 | 15 | 0.240 |
Why?
|
| Proto-Oncogene Proteins c-ret | 1 | 2025 | 39 | 0.240 |
Why?
|
| Iodine Radioisotopes | 1 | 2025 | 74 | 0.240 |
Why?
|
| Female | 23 | 2026 | 71086 | 0.230 |
Why?
|
| Intracranial Hemorrhages | 1 | 2026 | 79 | 0.230 |
Why?
|
| Arthralgia | 1 | 2026 | 77 | 0.230 |
Why?
|
| Pyridines | 1 | 2025 | 260 | 0.210 |
Why?
|
| Appendicitis | 2 | 2024 | 132 | 0.210 |
Why?
|
| Child, Preschool | 11 | 2025 | 15047 | 0.200 |
Why?
|
| Multiple Pulmonary Nodules | 1 | 2023 | 21 | 0.200 |
Why?
|
| Hip Dislocation, Congenital | 1 | 2023 | 26 | 0.200 |
Why?
|
| Carcinoma, Renal Cell | 2 | 2016 | 245 | 0.200 |
Why?
|
| Prospective Studies | 5 | 2024 | 6485 | 0.200 |
Why?
|
| Observer Variation | 1 | 2024 | 319 | 0.200 |
Why?
|
| Academic Medical Centers | 1 | 2025 | 322 | 0.200 |
Why?
|
| Solitary Pulmonary Nodule | 1 | 2023 | 31 | 0.190 |
Why?
|
| Circulating Tumor DNA | 1 | 2023 | 41 | 0.190 |
Why?
|
| Pyrazoles | 1 | 2025 | 358 | 0.190 |
Why?
|
| Osteosarcoma | 1 | 2025 | 265 | 0.190 |
Why?
|
| Natural Killer T-Cells | 1 | 2023 | 95 | 0.180 |
Why?
|
| Contrast Media | 3 | 2021 | 490 | 0.180 |
Why?
|
| Ganglioneuroblastoma | 1 | 2021 | 7 | 0.180 |
Why?
|
| Ganglioneuroma | 1 | 2021 | 17 | 0.180 |
Why?
|
| Reflex | 1 | 2021 | 36 | 0.180 |
Why?
|
| Kidney Neoplasms | 2 | 2016 | 454 | 0.170 |
Why?
|
| Pediatrics | 2 | 2021 | 1230 | 0.170 |
Why?
|
| Male | 18 | 2026 | 65158 | 0.170 |
Why?
|
| Gastrointestinal Motility | 1 | 2021 | 60 | 0.170 |
Why?
|
| Bone Neoplasms | 1 | 2025 | 444 | 0.170 |
Why?
|
| Thyroid Gland | 1 | 2021 | 99 | 0.170 |
Why?
|
| Teleradiology | 1 | 2020 | 7 | 0.160 |
Why?
|
| Meals | 1 | 2020 | 62 | 0.160 |
Why?
|
| Nuclear Medicine | 1 | 2020 | 7 | 0.160 |
Why?
|
| Neuroendocrine Tumors | 1 | 2021 | 59 | 0.160 |
Why?
|
| Multi-Institutional Systems | 1 | 2020 | 9 | 0.160 |
Why?
|
| Surveys and Questionnaires | 4 | 2024 | 4037 | 0.160 |
Why?
|
| Fractures, Bone | 1 | 2022 | 207 | 0.160 |
Why?
|
| Biological Transport | 1 | 2021 | 333 | 0.160 |
Why?
|
| Brain Neoplasms | 2 | 2023 | 1297 | 0.160 |
Why?
|
| Hospitals, Community | 1 | 2020 | 52 | 0.160 |
Why?
|
| Hip Joint | 3 | 2026 | 53 | 0.160 |
Why?
|
| Workload | 1 | 2021 | 153 | 0.160 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2021 | 239 | 0.150 |
Why?
|
| Acetabulum | 3 | 2024 | 19 | 0.150 |
Why?
|
| Sensitivity and Specificity | 4 | 2026 | 2143 | 0.150 |
Why?
|
| Burkitt Lymphoma | 1 | 2020 | 134 | 0.150 |
Why?
|
| Child Health Services | 1 | 2020 | 88 | 0.150 |
Why?
|
| Stomach | 1 | 2021 | 271 | 0.150 |
Why?
|
| Infant | 9 | 2025 | 13300 | 0.150 |
Why?
|
| Hospitals | 1 | 2022 | 444 | 0.150 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 3 | 2014 | 182 | 0.150 |
Why?
|
| Eating | 1 | 2020 | 379 | 0.140 |
Why?
|
| Neuroimaging | 1 | 2021 | 404 | 0.140 |
Why?
|
| Radionuclide Imaging | 3 | 2021 | 119 | 0.130 |
Why?
|
| Software | 1 | 2021 | 752 | 0.120 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 2016 | 113 | 0.110 |
Why?
|
| Stomach Neoplasms | 1 | 2020 | 578 | 0.110 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2020 | 775 | 0.100 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2016 | 489 | 0.100 |
Why?
|
| Inflammation | 1 | 2021 | 1490 | 0.100 |
Why?
|
| Emergency Service, Hospital | 1 | 2021 | 1217 | 0.100 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 3089 | 0.090 |
Why?
|
| Reproducibility of Results | 3 | 2024 | 2985 | 0.090 |
Why?
|
| Helicobacter pylori | 1 | 2020 | 1358 | 0.080 |
Why?
|
| Helicobacter Infections | 1 | 2020 | 1301 | 0.080 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2014 | 617 | 0.080 |
Why?
|
| Esophagus | 2 | 2021 | 237 | 0.080 |
Why?
|
| Epilepsy | 1 | 2017 | 889 | 0.080 |
Why?
|
| Prevalence | 2 | 2026 | 2692 | 0.070 |
Why?
|
| Adult | 6 | 2023 | 31666 | 0.070 |
Why?
|
| Infant, Newborn | 3 | 2025 | 8589 | 0.070 |
Why?
|
| Societies, Medical | 2 | 2023 | 794 | 0.070 |
Why?
|
| Lung | 1 | 2014 | 1565 | 0.060 |
Why?
|
| Treatment Outcome | 4 | 2024 | 12937 | 0.060 |
Why?
|
| Natural Language Processing | 1 | 2026 | 75 | 0.060 |
Why?
|
| Neoplasm Invasiveness | 1 | 2025 | 647 | 0.050 |
Why?
|
| Necrosis | 1 | 2024 | 194 | 0.050 |
Why?
|
| Short Bowel Syndrome | 1 | 2024 | 63 | 0.050 |
Why?
|
| Image Enhancement | 2 | 2014 | 172 | 0.050 |
Why?
|
| Osteotomy | 1 | 2023 | 47 | 0.050 |
Why?
|
| Arthroscopy | 1 | 2023 | 49 | 0.050 |
Why?
|
| Radiation Dosage | 1 | 2023 | 135 | 0.050 |
Why?
|
| Young Adult | 3 | 2023 | 10092 | 0.050 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2023 | 266 | 0.050 |
Why?
|
| Nausea | 1 | 2022 | 83 | 0.050 |
Why?
|
| Vomiting | 1 | 2022 | 104 | 0.040 |
Why?
|
| Radioisotopes | 1 | 2021 | 27 | 0.040 |
Why?
|
| Bronchi | 1 | 2021 | 102 | 0.040 |
Why?
|
| Constipation | 1 | 2022 | 130 | 0.040 |
Why?
|
| Receptors, Peptide | 1 | 2021 | 57 | 0.040 |
Why?
|
| Thyroidectomy | 1 | 2021 | 101 | 0.040 |
Why?
|
| Tertiary Care Centers | 1 | 2021 | 251 | 0.040 |
Why?
|
| Quarantine | 1 | 2020 | 18 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2023 | 828 | 0.040 |
Why?
|
| Efficiency, Organizational | 1 | 2020 | 58 | 0.040 |
Why?
|
| Triage | 1 | 2021 | 153 | 0.040 |
Why?
|
| Abdominal Pain | 1 | 2022 | 314 | 0.040 |
Why?
|
| Intestines | 1 | 2024 | 589 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2024 | 1516 | 0.040 |
Why?
|
| Ultrasonography, Interventional | 1 | 2020 | 204 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2024 | 1910 | 0.040 |
Why?
|
| Length of Stay | 1 | 2024 | 1393 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2023 | 934 | 0.030 |
Why?
|
| Patient Care Team | 1 | 2021 | 557 | 0.030 |
Why?
|
| Sex Factors | 1 | 2020 | 1345 | 0.030 |
Why?
|
| Everolimus | 1 | 2016 | 48 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2025 | 3834 | 0.030 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2023 | 961 | 0.030 |
Why?
|
| Antineoplastic Agents | 2 | 2016 | 1809 | 0.030 |
Why?
|
| Biomarkers, Tumor | 1 | 2023 | 1617 | 0.030 |
Why?
|
| Sirolimus | 1 | 2016 | 231 | 0.030 |
Why?
|
| Gadolinium DTPA | 1 | 2014 | 49 | 0.030 |
Why?
|
| Time Factors | 1 | 2024 | 6273 | 0.030 |
Why?
|
| Tyrosine | 1 | 2014 | 148 | 0.030 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2016 | 427 | 0.030 |
Why?
|
| Health Services Accessibility | 1 | 2020 | 695 | 0.030 |
Why?
|
| Indoles | 1 | 2014 | 205 | 0.020 |
Why?
|
| Pyrroles | 1 | 2014 | 186 | 0.020 |
Why?
|
| Forecasting | 1 | 2014 | 361 | 0.020 |
Why?
|
| Quality of Life | 1 | 2022 | 2107 | 0.020 |
Why?
|
| Texas | 1 | 2020 | 3614 | 0.020 |
Why?
|
| Mutation | 1 | 2023 | 6176 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2021 | 3113 | 0.020 |
Why?
|
| Mice | 1 | 2023 | 18470 | 0.010 |
Why?
|
| United States | 1 | 2020 | 11794 | 0.010 |
Why?
|
| Brain | 1 | 2014 | 3237 | 0.010 |
Why?
|
| Animals | 1 | 2023 | 34335 | 0.010 |
Why?
|
| Middle Aged | 1 | 2014 | 28839 | 0.010 |
Why?
|